Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura
| Data(s) |
08/04/2016
31/12/1969
|
|---|---|
| Formato |
application/pdf application/pdf |
| Identificador |
http://boris.unibe.ch/82404/2/JKH_blood-2016-03-703827_Rituximab%20reduces%20Risk...full.pdf http://boris.unibe.ch/82404/10/3092.full.pdf Page, Evaren E; Kremer Hovinga, Johanna Anna; Terrell, Deirdra R; Vesely, Sara K; George, James N (2016). Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood, 127(24), pp. 3092-3094. American Society of Hematology 10.1182/blood-2016-03-703827 <http://dx.doi.org/10.1182/blood-2016-03-703827> doi:10.7892/boris.82404 info:doi:10.1182/blood-2016-03-703827 info:pmid:27060171 urn:issn:0006-4971 |
| Idioma(s) |
eng |
| Publicador |
American Society of Hematology |
| Relação |
http://boris.unibe.ch/82404/ |
| Direitos |
info:eu-repo/semantics/embargoedAccess info:eu-repo/semantics/restrictedAccess |
| Fonte |
Page, Evaren E; Kremer Hovinga, Johanna Anna; Terrell, Deirdra R; Vesely, Sara K; George, James N (2016). Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood, 127(24), pp. 3092-3094. American Society of Hematology 10.1182/blood-2016-03-703827 <http://dx.doi.org/10.1182/blood-2016-03-703827> |
| Palavras-Chave | #610 Medicine & health |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |
